STAT

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

I’m Building an Algorithm That Doesn’t Rot Your Brain

I’m Building an Algorithm That Doesn’t Rot Your Brain transcript “Our brains are being melted by the algorithm.” [MUSIC ...

Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery Leader?

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off. Plus: Stop Hiding Your Wins

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, ...

The Algorithm Of Creativity: A Computational Framework For Deconstructing And Rebuilding Creativity

In today's volatile business landscape, relying on sporadic flashes of inspiration can be a fragile strategy for maintaining ...

Algorithm finds smallest dataset that guarantees optimal solutions to complex problems

Determining the least expensive path for a new subway line underneath a metropolis like New York City is a colossal planning challenge—involving thousands of potential routes through hundreds of city ...

OpenAI's Codex Max solves one of my biggest AI coding annoyances - and adds dramatically faster performance

Codex Max processes massive workloads through improved context handling. Faster execution and fewer tokens deliver better real-world efficiency. First Windows-trained Codex enhances cross-platform ...

OpenAI's Codex Max solves one of my biggest AI coding annoyances - and it's a lot faster

The SWE-Bench Verified evaluation is basically a test of AI processing accuracy. It measures how well the AI solves a set of coding problems. According to OpenAI, GPT-5.1-Codex-Max "reaches the same ...